MedDataX Logo

Evaluation of Laparoscopic Non Anatomical Liver Resection in Hepatic Pathology

NCT ID: NCT06166511

Last Updated: 2023-12-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-01-10

Study Completion Date

2025-05-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Laparoscopy is a type of surgical procedure that allows a surgeon to access the inside of the abdomen and pelvis without making large incisions in the skin.The use of laparoscopy in abdomenal surgeries increases for its great benefits over open surgery as:

1)faster recovery, 2)decrease blood loss, 3)shorter hospital stays, 4)decreased postoperative pain, 5)earlier return to work and resumption of normal daily activity as well as, 6)cosmetic benefits.

few studies discuss the efficacy and safety of using Laparoscopy in liver non anatomical resection.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

this study will include any male and female above 18 that presented with localized liver pathology (as benign hepatic tumours, resectable primary(HCC) or secondary malignancies, hydatid cyst any other hepatic cysts, haemangiomas,etc…...) and underwent laparoscopic non anatomical resection of liver in Assiut university hospitals. Investigators will record the time of operation, number of cases with intra operative mortality or complication and then follow up these patients during time of hospital stay for:

1\) post operative pain 2) secondary bleeding and 3) wound infection.

Then follow up these patients in out patient clinic visit for their:

1. satisfaction
2. cosmetic outcomes and
3. rate of recurrence of the pathology.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Laparoscopic Liver Resection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group undergo laparoscopic liver resection

Any patient from 18 to 65 and has localized liver pathology and underwent laparoscopic non anatomical resection of this pathology

Group Type EXPERIMENTAL

Laparoscopic liver resection

Intervention Type PROCEDURE

Using Laparoscopy in liver resection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Laparoscopic liver resection

Using Laparoscopy in liver resection

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* any male or female above 18 that has one of the following pathologies and underwent non anatomical hepatic resection:
* hepatic benign tumours as adenoma
* resectable secondary malignancies (2)
* any type of hepatic cysts e.g., hydatid cyst
* HCC on top of liver cirrhosis.

Exclusion Criteria

* 1\) any immunocompromised patient 2) Patient with contraindicdtions to use laparoscopy. 3) patient who are difficult to follow up.
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nader Nasih Adly

Resedent doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nader N Adly

Role: PRINCIPAL_INVESTIGATOR

Assuit University hospitals

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Assuit University hospitals

Asyut, Assuit, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

N N Adly

Role: CONTACT

Phone: 01206187141

Email: [email protected]

Abd El-moniem I El-khateeb, Prof

Role: CONTACT

Phone: 01005022533

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

R S Ibrahim, Assist Prof

Role: primary

Mahmoud H Abd El rizk, Lecturer

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Garlipp B, Gibbs P, Van Hazel GA, Jeyarajah R, Martin RCG, Bruns CJ, Lang H, Manas DM, Ettorre GM, Pardo F, Donckier V, Benckert C, van Gulik TM, Goere D, Schoen M, Pratschke J, Bechstein WO, de la Cuesta AM, Adeyemi S, Ricke J, Seidensticker M. Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trial. Br J Surg. 2019 Dec;106(13):1837-1846. doi: 10.1002/bjs.11283. Epub 2019 Aug 19.

Reference Type BACKGROUND
PMID: 31424576 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Laparoscopic liver resection

Identifier Type: -

Identifier Source: org_study_id